Business and Finance News 24/7
The market growth is driven by growing drug use after COVID-19 pandemic and increase in abuse of illicit drugs such as cannabis. Drug screening/drug of abuse testing offers a practical way to monitor and detect a person’s drug/alcohol use. Drug screening is frequently used at workplaces to test for illicit drug use that could affect […]
Continue Reading
The market growth is likely to be driven by growing demand for Inventory and Asset Management during work cycle and implementation of Unique Device Identification (UDI) regulations formed by the FDA. Surgical instrument tracking systems is a combination of latest scanning technology and application software for inventory management. It provides comprehensive surgical instrument management solution […]
Continue Reading
Integration of automation, AI, & machine learning (ML) in laboratory workflows, transformative benefits of laboratory automation, technological innovations in automation technology, and rising spending on healthcare are some of the key factors driving the growth of the global laboratory automation market. However, skill gap in technology, lack of skilled and trained healthcare professionals, and sluggish […]
Continue Reading
The rising support for RWE adoption from regulatory bodies, more financing from pharmaceutical firms, and the extra insights obtained over randomized clinical trials (RCTs) are driving the expansion of the worldwide market for real-world evidence solutions. Real-world evidence (RWE) is the clinical evidence regarding usage and potential benefits/risks of a medical product based on analysis […]
Continue Reading
Some of the major factors propelling the market growth are the high incidence and prevalence of cancer and HIV/AIDS, the growing emphasis on immunology and immuno-oncology research, the introduction of AI platforms in flow cytometry workflows, and the rise in R&D spending to create multicolor assays and cutting-edge reagents. The increased price of flow cytometry […]
Continue Reading
Growing demand for point-of-care (POC) testing services, the Covid-19 outbreak, government support to increase IVD kit production, the rising incidence of cancer and infectious diseases, cost savings, scalability, technology know-how, and risk mitigation provided by IVD contract manufacturers are among the key factors driving market growth. In-vitro diagnostics (IVD) are tests done on samples such […]
Continue Reading
Driven by the rising incidence of cancer and other targeted illnesses, the robust CGT pipeline, the fast-growing field of cell and gene therapy research, significant venture capital financing, and technical advancements. The development and approval of CAR-T cell therapies such as Kymriah and Yescarta and their success in combating hematological malignancies, has further boosted investment in CGT. Robust CGT pipeline with growing number of product approvals, strong support from large pharma and biotech, and consistent investor enthusiasm (~$20 bn raised in 2020) is set […]
Continue Reading
The primary drivers of this market are the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders; the growing use of digital pathology in research; the increasing incorporation of digital pathology in drug discovery and precision medicine programs; the growing acceptance of telepathology; and the adoption of digital pathology to improve efficiency […]
Continue Reading
Due to rising demand for patient-centered treatment and fast technology improvements. Furthermore, the trend toward preventative healthcare efforts and value-based care models accelerates the adoption of patient engagement solutions, fueling innovation and growth in the healthcare industry. Patient engagement solutions are a multidimensional strategy that uses digital advances and customized techniques to actively engage patients […]
Continue Reading
Some of the main drivers propelling the market expansion include the benefits of nanopore sequencing, which include high throughput and ultra-long reads; technical breakthroughs in nanopore technologies; increased expenditures in R&D; and the increasing occurrence of infectious illnesses. Nanopore Sequencing, a fourth-generation sequencing technology, in which single strands of DNA or RNA are passed through […]
Continue Reading